论文信息 - Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer - 字舞流文

Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer

Y. Akagi | S. Shichijo | K. Itoh | A. Yamada | Y. Takao | U. Toh | N. Iwakuma | Sayaka Sakurai | Shuko Saku | M. Okabe